MSLN and neoplasm: Across the entire cohort (Fig. 3A), MSLN low expression had a significant association with higher tumor mutation burden (TMB) and DNA mismatch repair (dMMR)/microsatellite instability-high (MSI-H) positivity in comparison to MSLN high expression.